Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade F 79.42 -1.53% -1.23
BLUE closed down 1.53 percent on Friday, December 6, 2019, on 87 percent of normal volume.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical BLUE trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
NR7 Range Contraction -1.53%
Multiple of Ten Bullish Other -1.53%
Fell Below 50 DMA Bearish -2.08%
Multiple of Ten Bullish Other -2.08%
Outside Day Range Expansion -2.08%
Upper Bollinger Band Touch Strength -2.08%
Crossed Above 50 DMA Bullish -6.42%
Above Upper BB Strength -6.42%

Older signals for BLUE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Medicine Biotechnology New Jersey Rare Diseases Medical Genetics Celgene Genetic Genealogy Human Diseases Summit

Is BLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 163.425
52 Week Low 71.42
Average Volume 1,032,049
200-Day Moving Average 118.43
50-Day Moving Average 82.60
20-Day Moving Average 76.96
10-Day Moving Average 78.98
Average True Range 3.66
ADX 26.42
+DI 24.68
-DI 17.92
Chandelier Exit (Long, 3 ATRs ) 74.35
Chandelier Exit (Short, 3 ATRs ) 82.41
Upper Bollinger Band 83.73
Lower Bollinger Band 70.19
Percent B (%b) 0.68
BandWidth 17.58
MACD Line -0.58
MACD Signal Line -1.76
MACD Histogram 1.1798
Fundamentals Value
Market Cap 3.62 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -10.83
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 83.53
Resistance 3 (R3) 83.84 82.77 82.85
Resistance 2 (R2) 82.77 81.73 82.62 82.62
Resistance 1 (R1) 81.10 81.08 80.57 80.79 82.39
Pivot Point 80.03 80.03 79.77 79.88 80.03
Support 1 (S1) 78.36 78.99 77.83 78.05 76.45
Support 2 (S2) 77.29 78.34 77.14 76.22
Support 3 (S3) 75.62 77.29 76.00
Support 4 (S4) 75.31